Tiberian Journal of Pharm and Lifescience Innovatives - Home page


                                                                                                                                                                                                                      

Tiberian Journal of Pharm and Lifescience Innovatives

Home page

                                                                                                                          
 
"Tiberian Journal of Pharm and Lifescience Innovatives (TJPLI)" is an online International Journal published as bi-annual in collaboration with Tiberia Publishers. It is a peer reviewed journal aiming to communicate high quality original research work, reviews, short communications, case report, Ethics Forum, Education Forum and Letter to editor that contribute significantly to further the Scientific Knowledge related to the field of Pharmacy and Lifesciences.

The journal’s full text is online at www.ejpli.at.ua. With the aim of faster and better dissemination of knowledge, we will be publishing articles immediately on acceptance. In addition, the journal would allow free access (Open Access) to its contents, which is likely to attract more readers and citations to articles published in TJPLI.

TJPLI is an Open Access Non Profit Journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. The Journal never charges any handling fees, publication fees or any similar from author or authors institution. 

 


 
                

Views: 4 | Added by: TibPubs | Date: 2012-05-18 | Comments (0)

RSS

Search

Login form

E-mail:
Password:

Calendar

«  May 2012  »
SuMoTuWeThFrSa
  12345
6789101112
13141516171819
20212223242526
2728293031

Statistics


Total online: 1
Guests: 1
Users: 0

Archive

Our poll

Rate my site
Total of answers: 39